Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)

Leukemia. 2023 Aug;37(8):1753-1756. doi: 10.1038/s41375-023-01964-3. Epub 2023 Jul 8.

Authors

Mark Gurney¹, Abhishek A Mangaonkar¹, Terra Lasho¹, Christy Finke¹, Aref Al-Kali¹, Naseema Gangat¹, Mithun V Shah¹, Hassan B Alkhateeb¹, Ayalew Tefferi¹, David Sallman², Zhuoer Xie², David Viswanatha³, Kaaren Reichard³, Najla Al Ali², Rami Komrokji², Eric Padron⁴, Mrinal M Patnaik⁵

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁴ Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. [email protected].
⁵ Division of Hematology, Mayo Clinic, Rochester, MN, USA. [email protected].

PMID: 37422593
DOI: 10.1038/s41375-023-01964-3

No abstract available

Publication types

Letter

MeSH terms

DNA Copy Number Variations
Humans
INDEL Mutation
Leukemia, Myelomonocytic, Chronic* / genetics
Nucleotides
Tumor Suppressor Protein p53 / genetics

Substances

Nucleotides
TP53 protein, human
Tumor Suppressor Protein p53